Medically reviewed by Steffini Stalos, DO Hemophilia disease is a rare inherited bleeding disorder. People with this genetic ...

Children with hemophilia have problems with dynamic balance and face an increased risk of falls compared with healthy peers, ...

Hemophilia A is a disorder that leads to nosebleeds, gastrointestinal bleeding, bruising, and more. The symptoms, which can be serious enough to require emergency care, occur due to a deficiency ...

HC Bioscience is shutting down after conducting preclinical models for a transfer RNA (tRNA) asset designed to treat hemophilia A. | The Cambridge, Massachusetts-based biotech is closing “following ...

“Gene therapy for hemophilia A with the use of lentiviral vector-transduced autologous HSCs resulted in stable factor VIII ...

Treatment involved an antithrombin-based dose regimen targeting antithrombin levels between 15% and 35%, starting at 50 mg once every 2 months, individually adjusted to 20, 50, or 80 mg monthly or 20 ...

The U.K.'s NICE recommended Altuvoct be available through the National Health Service (NHS) as a treatment for severe ...

Maharashtra haemophilia patients face medicine shortages, forcing travel to Gujarat for treatment, risking health and ...

Rising Prevalence of Hemophilia, Increasing Adoption of Recombinant Therapies, and Breakthroughs in Gene Therapy Propel Market Growth.Pune, March 12, 2025 (GLOBE NEWSWIRE) -- Hemophilia Market Size & ...

New treatments have changed the face of managing hemophilia with an inhibitor, columnist Cazandra Campos-MacDonald writes.

EMERYVILLE, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its ...